Home/Filings/4/0001593968-24-000562
4//SEC Filing

Parker Craig C 4

Accession 0001593968-24-000562

CIK 0001824893other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 5:27 PM ET

Size

14.3 KB

Accession

0001593968-24-000562

Insider Transaction Report

Form 4
Period: 2024-04-04
Parker Craig C
DirectorChief Executive Officer
Transactions
  • Purchase

    Series C Common Stock Warrant (right to buy)

    2024-04-04+5,7125,712 total
    Exercise: $16.00Common Stock (5,712 underlying)
  • Purchase

    Common Stock

    2024-04-04+1,4741,474 total
  • Purchase

    Series B Common Stock Warrant (right to buy)

    2024-04-04+1,6031,603 total
    Exercise: $15.71From: 2024-04-04Common Stock (1,603 underlying)
  • Purchase

    Series D Common Stock Warrant (right to buy)

    2024-04-04+5,7125,712 total
    Exercise: $16.00Common Stock (5,712 underlying)
  • Purchase

    Series A Common Stock Warrant (right to buy)

    2024-04-04+1,4741,474 total
    Exercise: $16.96From: 2024-04-04Exp: 2029-04-04Common Stock (1,474 underlying)
Footnotes (4)
  • [F1]On April 4, 2024, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of April 1, 2024, by and among the Issuer and certain institutional investors and members of management, at a purchase price of $16.96 per share, which amount includes $1.25 for the accompanying common stock warrants.
  • [F2]The warrant expires on the fifth trading day following the occurrence of the Series B Milestone Event (as defined in the Series B Common Stock Warrant). In the event the Series B Milestone Event has not occurred prior to the fifth anniversary of the issuance date of the warrant, the warrant will automatically terminate on such anniversary date.
  • [F3]The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series C Milestone Event (as defined in the Series C Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series C Common Stock Warrant).
  • [F4]The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series D Milestone Event (as defined in the Series D Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series D Common Stock Warrant).

Issuer

Surrozen, Inc./DE

CIK 0001824893

Entity typeother

Related Parties

1
  • filerCIK 0001526064

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:27 PM ET
Size
14.3 KB